Beijing’s Timeless Charm Goes Global
BEIJING, Oct. 31, 2025 /PRNewswire/ -- The 2025 Overseas Promotion of the Charming…
CHARM Therapeutics raises $80 million in Series B financing to advance development of best-in-class menin inhibitor for AML
New investors NEA and SR One lead round alongside existing investors OrbiMed,…
